1Stevelink, SAM, Jones, M, Hull, L, Pernet, D, MacCrimmon, S, Goodwin, L, et al. Mental health outcomes at the end of the British involvement in the Iraq and Afghanistan conflicts: a cohort study. Br J Psychiatry 2018; 213: 690–7.
2Nevin, RL. Re: ‘A decade of war: prospective trajectories of posttraumatic stress disorder symptoms among deployed US military personnel and the influence of combat exposure’. Am J Epidemiol 2018; 187: 1573–4.
3Magill, A, Cersovsky, S, DeFraites, R. Special considerations for US military deployments. In CDC Health Information for International Travel: The Yellow Book 2012 (ed Brunette, GW): 561–5. Oxford University Press, 2012.
4Livezey, J, Oliver, T, Cantilena, L. Prolonged neuropsychiatric symptoms in a military service member exposed to mefloquine. Drug Saf - Case Rep 2016; 3: 7.
5Nevin, RL. Mefloquine and posttraumatic stress disorder. In Textbook of Military Medicine. Forensic and Ethical Issues in Military Behavioral Health (ed Ritchie, EC): 277–96. Borden Institute, 2015.